vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Orion Group Holdings Inc (ORN). Click either name above to swap in a different company.

Orion Group Holdings Inc is the larger business by last-quarter revenue ($216.3M vs $143.8M, roughly 1.5× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 2.2%, a 22.1% gap on every dollar of revenue. On growth, Orion Group Holdings Inc posted the faster year-over-year revenue change (14.6% vs 2.9%). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs 6.1%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

CNS vs ORN — Head-to-Head

Bigger by revenue
ORN
ORN
1.5× larger
ORN
$216.3M
$143.8M
CNS
Growing faster (revenue YoY)
ORN
ORN
+11.8% gap
ORN
14.6%
2.9%
CNS
Higher net margin
CNS
CNS
22.1% more per $
CNS
24.3%
2.2%
ORN
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
6.1%
ORN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CNS
CNS
ORN
ORN
Revenue
$143.8M
$216.3M
Net Profit
$34.9M
$4.7M
Gross Margin
12.0%
Operating Margin
28.0%
Net Margin
24.3%
2.2%
Revenue YoY
2.9%
14.6%
Net Profit YoY
-23.9%
435.7%
EPS (diluted)
$0.67
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
ORN
ORN
Q1 26
$216.3M
Q4 25
$143.8M
$233.2M
Q3 25
$141.7M
$225.1M
Q2 25
$136.1M
$205.3M
Q1 25
$134.5M
$188.7M
Q4 24
$139.8M
$216.9M
Q3 24
$133.2M
$226.7M
Q2 24
$121.7M
$192.2M
Net Profit
CNS
CNS
ORN
ORN
Q1 26
$4.7M
Q4 25
$34.9M
$-240.0K
Q3 25
$41.7M
$3.3M
Q2 25
$36.8M
$841.0K
Q1 25
$39.8M
$-1.4M
Q4 24
$45.8M
$6.8M
Q3 24
$39.7M
$4.3M
Q2 24
$31.8M
$-6.6M
Gross Margin
CNS
CNS
ORN
ORN
Q1 26
12.0%
Q4 25
11.6%
Q3 25
13.2%
Q2 25
12.6%
Q1 25
12.2%
Q4 24
14.0%
Q3 24
11.9%
Q2 24
9.5%
Operating Margin
CNS
CNS
ORN
ORN
Q1 26
Q4 25
28.0%
2.2%
Q3 25
34.5%
2.4%
Q2 25
31.8%
1.7%
Q1 25
33.6%
0.4%
Q4 24
35.3%
4.4%
Q3 24
33.7%
3.4%
Q2 24
31.5%
-1.4%
Net Margin
CNS
CNS
ORN
ORN
Q1 26
2.2%
Q4 25
24.3%
-0.1%
Q3 25
29.4%
1.5%
Q2 25
27.1%
0.4%
Q1 25
29.6%
-0.7%
Q4 24
32.8%
3.1%
Q3 24
29.8%
1.9%
Q2 24
26.1%
-3.4%
EPS (diluted)
CNS
CNS
ORN
ORN
Q1 26
$0.12
Q4 25
$0.67
$-0.00
Q3 25
$0.81
$0.08
Q2 25
$0.72
$0.02
Q1 25
$0.77
$-0.04
Q4 24
$0.89
$0.22
Q3 24
$0.77
$0.12
Q2 24
$0.63
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
ORN
ORN
Cash + ST InvestmentsLiquidity on hand
$145.5M
$6.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
$166.7M
Total Assets
$876.7M
$478.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
ORN
ORN
Q1 26
$6.3M
Q4 25
$145.5M
$1.6M
Q3 25
$98.1M
$4.9M
Q2 25
$95.4M
$1.7M
Q1 25
$65.2M
$13.0M
Q4 24
$183.0M
$28.3M
Q3 24
$106.5M
$28.3M
Q2 24
$122.0M
$4.8M
Total Debt
CNS
CNS
ORN
ORN
Q1 26
Q4 25
Q3 25
Q2 25
$33.4M
Q1 25
$23.3M
Q4 24
$23.2M
Q3 24
$28.0M
Q2 24
$60.3M
Stockholders' Equity
CNS
CNS
ORN
ORN
Q1 26
$166.7M
Q4 25
$562.0M
$159.0M
Q3 25
$550.3M
$157.9M
Q2 25
$528.5M
$153.2M
Q1 25
$507.7M
$150.8M
Q4 24
$511.7M
$150.7M
Q3 24
$491.0M
$142.4M
Q2 24
$463.2M
$111.1M
Total Assets
CNS
CNS
ORN
ORN
Q1 26
$478.7M
Q4 25
$876.7M
$414.7M
Q3 25
$801.6M
$422.4M
Q2 25
$751.0M
$432.7M
Q1 25
$834.9M
$416.3M
Q4 24
$812.4M
$417.3M
Q3 24
$727.8M
$430.3M
Q2 24
$784.1M
$414.0M
Debt / Equity
CNS
CNS
ORN
ORN
Q1 26
Q4 25
Q3 25
Q2 25
0.22×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.20×
Q2 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
ORN
ORN
Operating Cash FlowLast quarter
$-120.4M
Free Cash FlowOCF − Capex
$-126.4M
FCF MarginFCF / Revenue
-87.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
ORN
ORN
Q1 26
Q4 25
$-120.4M
$13.8M
Q3 25
$55.1M
$23.3M
Q2 25
$-67.6M
$-5.6M
Q1 25
$-108.9M
$-3.4M
Q4 24
$96.7M
$13.4M
Q3 24
$25.6M
$37.5M
Q2 24
$31.4M
$-15.3M
Free Cash Flow
CNS
CNS
ORN
ORN
Q1 26
Q4 25
$-126.4M
$454.0K
Q3 25
$52.6M
$13.9M
Q2 25
$-69.8M
$-12.7M
Q1 25
$-110.0M
$-12.5M
Q4 24
$85.0M
$9.9M
Q3 24
$24.2M
$33.3M
Q2 24
$27.1M
$-20.0M
FCF Margin
CNS
CNS
ORN
ORN
Q1 26
Q4 25
-87.9%
0.2%
Q3 25
37.1%
6.2%
Q2 25
-51.3%
-6.2%
Q1 25
-81.8%
-6.6%
Q4 24
60.8%
4.6%
Q3 24
18.2%
14.7%
Q2 24
22.3%
-10.4%
Capex Intensity
CNS
CNS
ORN
ORN
Q1 26
Q4 25
4.2%
5.7%
Q3 25
1.8%
4.2%
Q2 25
1.6%
3.5%
Q1 25
0.8%
4.8%
Q4 24
8.3%
1.6%
Q3 24
1.1%
1.8%
Q2 24
3.5%
2.4%
Cash Conversion
CNS
CNS
ORN
ORN
Q1 26
Q4 25
-3.45×
Q3 25
1.32×
7.05×
Q2 25
-1.84×
-6.61×
Q1 25
-2.74×
Q4 24
2.11×
1.98×
Q3 24
0.65×
8.79×
Q2 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons